Kai-Hsin Chang

Company: Editas Medicine

Job title: Vice President, Translational Sciences

Seminars:

Early Results From the First Cas12-Mediated Clinical Trial 9:00 am

Outlining the rationale behind selecting AsCas12a and potential differentiation Presenting interim safety and efficacy data from ongoing AsCas12a based clinical trials Key considerations for the future of genome editing clinical developmentRead more

day: Day 1 AM